MENU
CRBU
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Caribou Biosciences (CRBU) Ownership - Who owns Caribou Biosciences?
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies... Show more
Profile
Industry
N/A
Address
2929 7th Street
Phone
+1 510 982-6030
Employees
158
Web
https://www.cariboubio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
101.38M
P/E Ratio
N/A
Total Cash
208.47M
Projected Growth
N/A
Total Debt
26.22M
Revenue
9.92M
Risk (Beta)
2.50
Dividend Yield
N/A
Total Cash/Share
2.24
Total Debt/Equity
N/A
Revenue/Share
0.11 USD as % of share price
Fundamentals
CRBU
Capitalization
101M
P/E Ratio
N/A
Risk (Beta)
2.50
Dividend Yield
N/A
Total Cash
208M
Total Cash/Share
2.24
Total Debt
26.2M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.11%
Revenue
9.92M
ROE
N/A
Book Value
217M
P/B Ratio
0.47
Cash Flow
N/A
Earnings
-1.62
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9K
Current Ratio
7.63
Current Revenue Per Employee
16006.80
Dividends Per Share - Security
N/A
EBITDA
-159.14M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-43.46
Shares Held By Institutions
110M
Shares Outstanding - Current
93M
Total Liabilities
56.4M
Total Volume MTD
N/A
Value
1
Gain YTD
-31.447
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2929 7th Street
Phone
+1 510 982-6030
Employees
158
Web
https://www.cariboubio.com